Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xenon inhalation and erythropoietin levels in healthy volunteers
2014-000973-38Phase 3Terminated
- Sponsor
- RWTH Aachen University
- Start
- Mar 2014
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of xenon xe-133, sponsored by RWTH Aachen University. Primary endpoint: Change in erythropoietin levels over time after xenon inhalation. Started Mar 2014; status: terminated.
02
Drugs
xenon xe-133
Beyond the preview
Go deeper on 2014-000973-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000973-38.